SCHEMBL30745833

SCHEMBL30745833

COc1ccc(CS(=O)(=O)c2ccccc2OC)cc1F

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
MAPK1 P28482 1/20 0.46
TP53 P04637 1/20 0.45
KDM1A O60341 1/20 0.44
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
MAPT P10636 1/20 0.44
RAB9A P51151 1/20 0.43
MAPK10 P53779 1/20 0.43
HSD17B10 Q99714 1/20 0.43
HTR6 P50406 1/20 0.43
USP2 O75604 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29665700 0.79 TUBB1 (0.43) LMNAHTTSMN1; SMN2ALDH1A1MAPK1
SCHEMBL7535556 0.79 TUBB1 (0.43) LMNAHTTSMN1; SMN2ALDH1A1MAPK1
SCHEMBL4247206 0.76 HTR6 (0.58) HTTSMN1; SMN2TP53HTR6KDM4E
SCHEMBL24458142 0.75 TUBB1 (0.39) LMNAHTTALDH1A1MAPK1RAB9A
SCHEMBL29665751 0.75 TUBB1 (0.39) LMNAHTTALDH1A1MAPK1RAB9A
SCHEMBL7536230 0.75 HTT (0.41) LMNAHTTALDH1A1MAPK1RAB9A
SCHEMBL24458182 0.74 HTT (0.41) LMNAHTTALDH1A1MAPK1MAOB
SCHEMBL21760970 0.73 SMN1; SMN2 (0.51) LMNAHTTSMN1; SMN2ALDH1A1MAPT
SCHEMBL27020044 0.73 LMNA (0.45) LMNAHTTSMN1; SMN2ALDH1A1HPGD
SCHEMBL28835130 0.73 ALDH1A1 (0.50) HTTSMN1; SMN2ALDH1A1HTR6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO, INC. (CA) 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018153-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF ABCG2, ABCB1, ARSA LMNA 992/4885HTT 311/4885SMN1; SMN2 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.